EquityFlowCompanies › Hippo Dx

Hippo Dx

Healthtech · BE

Medtech with an automated skin-prick (SPAT) allergy testing device.

Funding history

DateRoundAmount
Oct 2023Funding round
Belgian medtech Hippo Dx raised EUR4.4M, with LRM and Allerfund Ventures, to scale its automated allergy testing device internationally.
$4.7M

Investors

Allerfund VenturesLRM

Similar companies in Healthtech

Explore funding flow on EquityFlow →